Keytruda Market - PD-1 Inhibition and Immune Checkpoint Blockade

added blog Wellness

2026-08-17 06:57:01 -

Market Overview The global Keytruda (pembrolizumab) market is experiencing explosive growth driven by cancer immunotherapy adoption, indication expansion, and breakthrough efficacy. The Keytruda market is projected to exceed USD 24.6 billion through 2030, fueled by cancer patients exceeding 20 million annually, indication broadening, and therapeutic dominance. Keytruda represents immunotherapy...

0 Comments 0 Shares 66 Views 0 Reviews